enGene Holdings Appoints Ron Cooper as CEO

Boston, MA and Montreal, Canada, July 24, 2024 (Business Wire) -- enGene Holdings has appointed Ron Cooper as CEO, effective July 22, 2024. This move follows a succession plan that will see Jason Hanson remain with the company as a strategic advisor. Cooper's new role marks a key moment in enGene’s progress with its lead product candidate for bladder cancer.

Read full article here.